Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation

Clinical Nephrology

Volumn 71, Issue 4, 2009, Pages 423-429

  Kliem, V ^a   Michel, U ^b   Burg, M ^a   Bock, A ^c   Chapman, J ^d   Dussol, B ^e   Fritsche, L ^f   Lebranchu, Y ^g   Oppenheimer, F ^h   Pohanka, E ⁱ   Salvadori, M ^j   Tufveson, G ^k  

^a Nephrological Center Niedersachsen   (Germany)

^b Novartis Pharma GmbH   (Germany)

^c CANTONAL HOSPITAL AARAU   (Switzerland)

^d UNIVERSITY OF SYDNEY   (Australia)

^e HÔPITAL DE LA CONCEPTION   (France)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g CHU BRETONNEAU   (France)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j CAREGGI UNIVERSITY HOSPITAL   (Italy)

^k UPPSALA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Hepatitis B; Hepatitis C; Renal transplantation

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; GLOMERULUS FILTRATION RATE; GRAFT INFECTION; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY CANCER; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETRANSPLANTATION; RISK FACTOR; TREATMENT DURATION; VIRUS INFECTION;

EID: 66649107243     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71423     Document Type: Article

References (33)

1. Aroldi A, Lampertico P, Montagnino G, Lunghi G, Passerini P, Villa M, Campise M, Cesana BM, Ponticelli C. Natural history of hepatitis C virus infection in adult renal graft recipients. Transplant Proc. 2005; 37: 940-941.
2. Batty DS Jr, Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant. 2001; 1: 179-184.
3. Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR. Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Transplant Proc. 2005; 37: 3045-3047.
4. Bruchfeld A, Wilczek H, Elinder CG. Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation. Transplantation. 2004; 78: 745-750.
5. Caillard S, Lelong C, Pessione F, Moulin B. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from French registry. Am J Transplant. 2006; 6: 2735-2742.
6. Chan TM, Lok ASF, Cheng IKP. Hepatitis C in renal transplant recipients. Transplantation. 1991; 52: 810-813.
7. Chan TM, Chapman J, Lee CJ, Morad Z, Ona ET, Park K, Pingle A, Rizvi SA, Shaheen FA, Sumethkul V, Tang XD, Watarai Y. A survey on the prevalence and management of hepatitis B after renal transplantation in Asian-Pacific countries. Transplant Proc. 2004; 36: 2126-2127.
8. Correa JR, Rocha F, Peres AA, Gončalves LF, Manfro RC. Long-term impact of hepatitis Band C virus infection in kidney transplant recipient's survival. Transplant Proc. 2003; 35: 1076-1077.
9. Einollahi B, Hajarizadeh B, Bakhtiari S, Lesanpezeshki M, Khatami MR, Nourbala MH, Pourfarziani V, Alavian SM. Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol. 2003; 18: 836-840.
10. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant. 2005; 5: 1452-1461.
11. Fabrizi F, Martin P, Dixit V, Kanwal F, Dulai G. HBsAg-seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant. 2005; 5: 2913-2921.
12. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: metaanalysis of clinical studies. Am J Transplant. 2005; 5: 2433-2440.
13. Hirakauva EY, Ferraz ML, Perez RM, Ferreira AS, Silva AE, Hauache O, Pestana JO. Prevalence of diabetes mellitus in renal transplant patients with hepatitis B or C virus infection. Transplant Proc. 2002; 34: 3220-3222.
14. Ingsathit A, Thakkinstian A, Kantachuvesiri S, Sumethkul V. Different impacts of hepatitis B virus and hepatitis C virus on the outcome of kidney transplantation. Transplant Proc. 2007; 39: 1424-1428.
15. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990; 12: 671-675.
16. Kliem V, Ringe B, Holhorst K, Frei U. Kidney transplantation in hepatitis B surface antigen carriers. Clin Invest. 1994; 72: 1000-1006.
17. Kliem V, van den Hoff U, Brunkhorst R, Tillmann HL, Flik J, Manns MP, Pichlmayr R, Koch KM, Frei U. The long-term course of hepatitis C after kidney transplantation. Transplantation. 1996; 62: 1417-1421.
18. Kliem V, Fritsche L, Haller H, Suwelack B, Abendroth D, Fornara P, Pietruck F, Frei U, Donauer J, Lison AE, Michel U, Ulbricht B. Cyclosporine-based immuno-suppressive strategies for kidney recipients: interim analysis of German data from the multinational observational study (MOST). Transplant Proc. 2005; 37: 1597-1600.
19. La Quaglia MP, Tolkoff-Rubin NE, Dienstag JL, Cosimi AB, Herrin JT, Kelly M, Rubin RH. Impact of hepatitis in renal transplantation. Transplantation. 1981; 32: 504-507.
20. Lin H-H, Huang C-C, Huang J-Y, Yang C-W, Wu M-S, Fang J-T, Yu C-C, Chiang Y-J, Chu S-H. Impact of HCV infection on first cadaveric renal transplantation, a single-center experience. Clin Transplant. 2004; 18: 261-266.
21. Manga Sahin G, Sahin S, Kantarci G, Ergin H. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation. Transplant Proc. 2006; 38: 499-501.
22. Mitwalli AH, Alam A, Al-Wakeel J, Al Suwaida K, Tarif N, Schaar TA, Al Adbha B, Hammad D. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients. Nephron Clin Pract. 2006; 102: c72-c80.
23. Morales JM, Domínguez-Gil B, Sanz-Guajardo D, Fernández J, Escuin F. The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure. Nephrol Dial Transplant. 2004; 19 (Suppl. 3): iii72-iii76.
24. Narula AS, Hooda A, Anand AC, Patrikar S. Impact of hepatitis C virus infection in renal transplant recipients. Ind J Gastroenterol. 2005; 24: 151-154.
25. Pedroso S, Martins L, Fonseca I, Dias L, Henriques AC, Sarmento AM, Cabrita A. Impact of hepatitis C virus on renal transplantation: association with poor survival. Transplant Proc. 2006; 38: 1890-1894.
26. Sabet S, Hakemi M, Nadjafi I, Ganji MR, Argani H, Broumand B. Impact of hepatitis C virus infection on short-term outcome in renal transplantation: a single-center study. Transplant Proc. 2003; 35: 2699-2700.
27. Salvadori M, Rosati A, Bock A, Chapman J, Dussol B, Fritsche L, Jeffrey J, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G. One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST observational study. Transplant Proc. 2003; 38: 2863-2867.
28. Salvadori M, Rosati A, Bertoni E, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G, Soergel M. Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study. Transplant Proc. 2006; 38: 1010-1013.
29. Sens YA, Silva VD, Malafronte P, Souza JF, Miorin LA, Jabur P. Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus. Transplant Proc. 2004; 36: 886-888.
30. Silkensen JR. Long-term complications in renal transplantation. J Am Soc Nephrol. 2000; 11: 582-588.
31. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995; 322: 1463-1466.
32. Unal E, Turkmen F, Sevinc C, Kiziler AR, Aydemir B, Titiz I. Outcome of renal allograft in Turkish patients with pretransplantation hepatitis C virus infection. Transplant Proc. 2006; 38: 3448-3450.
33. Weir MR, Kirkman RL, Strom TB, Tilney NL. Liver disease in recipients of long-functioning renal allografts. Kidney Int. 1985; 28: 836-844.